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GENETIC DISCRM[INATION IN THE WORKPLACE
AND THE NEED FOR FEDERAL LEGISLATION
HeatherRae Watterson

INTRODUCTION
In his State of the Union Address, President Clinton "urged Americans
to prevent the misuse of genetic testing for discrimination against
individuals." 1 A week earlier, Vice President Al Gore announced his
support for federal legislation to prohibit employers from2
discriminating against employees based on their genetic profile.
Genetic discrimination is on the rise and will become increasingly3
prevalent with the completion of the Human Genome Project (HGP).
The HGP was initiated in 1990, with its purpose to identify and map
the genes in the human body.4 Ultimately, the HGP, which is set to be
completed by the year 2005, will lead to the treatment,
curing and
5
disorders.
genetic
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Although geneticists believe that the ability to identify the genes
offers tremendous medical benefits, it also poses severe legal and
ethical dilemmas. 6 State legislatures have identified the legal and
ethical dilemmas associated with the HGP and have begun to initiate
statutes to prevent against such discriminatory use.7 At present, states
have begun to promulgate statutes that prohibit genetic discrimination
in employment and insurance, that either regulates insurance companies
from gaining access to confidential information or prohibits employers
from using8 the private information to discriminate against the
employees.
Despite the growing awareness from both state legislatures and
federal officials, there is no federal law that adequately prevents an
employer from gaining access to private medical information and usin, )
that information to discriminate against the employee or applicant.
This paper analyzes the implications of genetic testing in the workplace
and the need for greater federal intervention to protect against genetic
discrimination. The first section provides an overview of genetics and
genetic testing. The second section outlines the current federal
protection under the Americans with Disabilities Act (ADA) and the
Health Insurance and the Portability Accountability Act (HIPAA) and
analyzes why both Acts fail to adequately prevent genetic
discrimination in the workplace. The third section provides an
overview of the federal legislation that was proposed by the 105th
6

Larry Gostin, Genetic Discrimination: The Use of Genetically Based Diagnostic and
ProgiosticTests by Employers and Insurers, 17 AM. J.L. & MED. 109, 110 (1991). The HGP

will have an immediate and major impact on medicine. The ability to map the genes and the
diseases/disorders associated with the gene will enhance the ability to predict a person's future
potential to develop the disability and lead the medical community to understanding the
etiology of the disorder. Understanding the etiology of a disorder can help lead to disease
prevention, through genetic counseling and treatment, and through genetic manipulation, which
can eliminate genetic disorders altogether. See Dogramaci, supra note 5, at ISO. In addition to
the medical benefits of the HGP, scientists believe that the with the completion of the HGP,
will have positive affects on anthropology, DNA forensics and identification, agriculture,
livestock breeding, and bioprocessing. See also www.Oml.gov/hgmis/project/benefits.html.
7

Melinda Kaufinann, Genetic Discriminationin the Workplace: An Overview ofExisting
Protections,30 LOy. U. Cri. L.J. 393 (1999).
sSandra Hurd and Rosemary Orthmann, States Mull Genetic Testing Issuing in 1998,
LAW AND POLICY REPORTER, May 1998, at 65; Tara L. Rachinsky, Genetic Testing: Toward a
Comprehensive Policyto Prevent Genetic Discriminationin the Workplace, 2 U. PA. J. LAB, &
EMP. L. 575 (Winter 2000).
9
See Kaufmann, supra note 7, at 436.
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Congress and discusses why such federal legislation must be passed.
The final section provides a brief discussion of the current strides that
have been made to prevent genetic discrimination throughout this
millenium.
AN OVERVIEW OF GENETICS, THE HUMAN GENOME
PROJECT AND GENETIC TESTING
An Introduction Into Genetics
"Genetics is the study of how physical and mental features of an
organism are passed down to their offspring. ' 1° Due to the rapid
developments in technology our understanding of genetics has
increased." Scientists have also increased their knowledge of how to
change and edit the genetic code, allowing them to recreate or edit
12
life.
Deoxyribonucleic Acid
The "human genome", the complete set of instructions for making up
an organism, contains the master blueprint for the cellular structure for
the lifetime of the cell.1 3 The human genome is made up of 23
pairs of
14
chromosomes, each containing deoxyribonucleic acid (DNA).
"[A] DNA molecule consists of two strands that wrap around each
other."' 5 These strands of DNA are termed chromatin and are
"composed of four kinds of molecular sub-units called nucleotides .... 16
"Each nucleotide contains one sugar, one phosphate, one of four
nitrogen bases, consisting of: adenine (A), thymine (T), cytosine (C),
and guanine (G)."' 17 The genetic code of any particular organism

10

Available at vww.geocities.com

1id.

12Id.

'3Available at www.om.gov/hgmisprojectinfo.html.
' 4See Colby, supra note 3, at 446. If unwound, the strands of DNA would stretch more
than 5 feet. The components of each strand, contains the entire coding for all the information
necessary for maintaining life.
5
'Available at w.om.gov/hgmislprojectlinfo.html.
16See David Suzuki & Peter Knudtson, Gencthics: The Clash Bc'lvtccn Gcncttcs and
Human Values (rev. ed. 1990), cited in Colby, supra note 3, at 445 n.4.
'71d at n.26
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utilizes these four nucleotides, in addition to the sugar8 and phosphate,
as the chemical instructions of hereditary information.'
Genes
A gene, the physical and function units of heredity, is the specific
sequence of the nucleotide bases. 19 The ordering of the nucleotides are
composed of three units call codons. 20 Sixty-four codons make up the
entire genetic code, which is responsible for making amino acids, the
building blocks of all living organisms. 21 The particular sequences also
carry the information necessary for creating proteins.22 The genetic
code, therefore, is a series of the codons that determine which
grouping
23
of amino acids are required to make up specific proteins.
These proteins are transmitted through the messenger ribonucleic
acid (mRNA), where the RNA strand is produced from the DNA inside
the nucleus. 24 The nRNA can be isolated in a laboratory setting, and
25
used as a "template to synthesize a complementary DNA strand"
assisting scientists in mapping the corresponding gene on a
chromosomal map.26
Chromosomes
The 3,000,000,000 base pairs are organized into 24 sub-units called
chromosomes.27 The nucleus of most cells contains two sets of
chromosomes, one set from the mother and one from the father.2 8 Each

' 8Eric Holmes, Solving he Insurance/GeneticsFair/UnfairDiscriminationDilemma in
Light of the Human Genome Project, 85 K.Y.L.J. 503, 521 (1996-1997); See also
wvww.oml.gov/hgmis/project/info.html.
19Available at wwwv.omi.gov/hgmis/project/info.htrnl.
20
2 1See Holmes, supra note 18, at 521.
id.
=Available at www.oml.gov/hgmis/projectlinfo.htnl. Humans can synthesize about
80,000 different kinds of proteins. Each proteins are made up of amino acids. Id.

MId.
24

d. RNA is an intermediary molecule similar to a single strand of DNA. The "mRNA is

moved from the nucleus to the cellular cytoplasm, where it serves as the template for protein
synthesis. The cells' proteins-synthesizing machinery then translates the codons into a string of
amino acids that will constitute the protein molecule for which it codes." Id.
25
26 Id. The complimentary DNA is abbreviated cDNA.
27

d.

Available at www.oml.gov/hgmis/project/info.html.

28
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set of chromosomes has 23 single 29 chromosomes, consisting of an 'X'
or 'Y' sex chromosome. A normal female will have a pair of 'X'
chromosomes 30 and a normal male will have an 'X' and a 'Y'
chromosome.
In some cases, abnormalities can occur.
Some of these
abnormalities are apparent through microscopic testing, whereby
scientists can discover missing or extra chromosomes, such as Down's
Syndrome.3 1 Most DNA mutations, however, are too subtle to be seen
32
by the eye and can only be discovered through molecular analysis.
Being able to identify the mutation depends upon being able to identify
the gene or group of genes associated with a particular disorder or
disease. The HGP has begun to do just that.
The Human Genome Project
The HGP, a federally funded project, was initiated by scientists in 1990
and is set to meet its goal of sequencing the entire human genome in
the year 2005.33 This project is now an international affair, including
research being done in the United Kingdom, France, Italy, Japan, and
Russia.34 The United States HGP initially began as a $3,000,000,000,
fifteen-year program to locate the 100,000 human genes and sequence
the nearly 3 billion DNA building blocks.35 In the early phases of the
project, scientists focused their efforts on creating the biological,
instrumentation, and computing resources necessary for efficient DNA
sequencing. 36 Because of the rapid technological progress, the plan
was revised in 1993 and scientists began projecting its goals through
1998. 37 Scientists believed that they would complete the project by
2003, two years earlier than originally planned.3 a
9Id.
30

1d.

31Id.
2

' Available at www.oml.gov/hgmifprojectlinfo.htm. For example, cystic fibrosis can
only be determined through genetic testing.
3See Colby, supra note 3, at 445. The human genome is the 100,000 genes in the 23

pairs of chromosomes.
34Tara L. Rachinsky, Genetic Testing: Toward a Comprehensive Policy to Prvent
Genetic Discriminationin the Morlq.lace, 2 U.PA. L LB. & E.m.p. L. 575, 580 (Winter, 2000).
"SAvailable at wwwv.oml.gov/igmisfproject/info.htim.
361d.
37Id.

331d.
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With the HGP, scientists have been able to map all forty-six
chromosomes, but only one-percent of the 3 billion pairs have actually
been sequenced. 39 The research from the HGP continues to discover
the particular gene(s) responsible for certain disorders.40 Although
some of the genetic disorders are in fact focused on a single gene
defect, most are caused by the interaction of environmental factors and
numerous abnormal genes or chromosomes. 41 By engaging in gene
mapping, scientists have been able to discover how the interaction of
factors lead to disorders
and what gene or set of genes are responsible
42
mutation.
the
for
This discovery has had tremendous impact within the medical and
scientific communities. 43 The results have affected (1) agriculture and
livestock breeding, (2) microbial genomics, (3) risk assessment, (4)
bioarchaelogy, (5) anthropology, (6) DNA forensics, and (7) molecular
medicine.
The HGP has focused on plants and animals, in addition to human
cells. By studying plant and animal genomes, researchers have begun
to create more disease-resistant plants, reducing the costs of agriculture
and providing consumers with more pesticide-free foods.44 The
benefits extend into the environment, leading researchers to utilize
biomanufacturing, which uses nontoxic chemicals and enzymes that not
only reduce
the costs, but also provides a healthier alternative for the
45
consumer.

By examining the human genome, scientists have begun to
understand human evolution and the common biology that many
organisms share, in addition to the relationships among the three
kingdoms: archaebacteria, eukaryotes, and prokaryotes. 46 Additionally,
scientists have been able to compare breakpoints in
evolution of
47
events.
historical
and
population
of
ages
with
mutations
39

See Holmes, supra note 18, at 522-23. Gene mapping is the process where scientists
associate
40 certain diseases with a gene or group of genes. See also Colby, supra note 3, at 447.
1d. at 523.
41
Id at 522.
42
See also Colby, supra note 3, at 448.

43

Id.

44Available
at www.oml.gov/html/project/benefits.html
45

1d.

46

1d.

47_1d.
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Gene mapping has also led to the ability to identify individuals
based on the gene structure. By examining DNA and the human
genome, scientists can now identify paternity and other family
relationships and identify potential suspects whose DNA may match
evidence left at the scene of a crime.
Within molecular medicine, researchers have uncovered, and vill
continue to uncover, the genes associated with genetic conditions,
including cystic fibrosis, fragile X syndrome, and Alzheimer's disease.
By understanding the etiology of diseases, scientists can begin to utilize
disease prevention, through genetic counseling, and disease treatment,
through genetic manipulation,
leading to the eventual elimination of all
48
genetic disorders.
With the benefits and opportunities obtained from the HGP come
the possibility of social detriment. The ability to determine the genetic
makeup of an individual, can lead to a certain stigma, whereby the
information could be used, for example, to determine custody in a
custody battle, or determine whether potential adoptive parents are
appropriate. 49 Additional discrimination is likely to occur. An
employer or insurance carrier can take a simple blood test and obtain
the complete genetic profile of any individual. 0 The employer wAll
have the ability to identify any genetic disorders, such as sickle-cell
51
anemia and cystic fibrosis, of the employee or applicant.
Complicating the matter even more, the employer will be able to
determine whether the employee or applicant has the potential to
develop a wide range of physical conditions, such as heart disease,
cancer, or schizophrenia. 52 With this personal medical information, the
employer can then refuse to hire the applicant because of his or her
disorder or susceptibility to develop the disorder.

4

8See also Gostin, supra note 6, at 110.
1d. See also Kaufmann, supra note 7, at 393.

49

50

5 11d.

id
5See Lance Liebman, Too Much Information: Predictionsof Employce Disease and the
FringeBenefit System, 1988 U. Cli. LEGAL F. 57.
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Genetic Testing
Because the HGP has begun to identify the genetic disorders associated
with genes, genetic testing is on the rise. Genetic testing 53 involves
analyzing an individual's DNA 54 or proteins, focusing on the sequence
and the discovery of any mutated genes. 55 There are three types of
conditions that genetic testing can reveal.
First, genetic testing can reveal with an individual has a genetic
disorder, such as cystic fibrosis or sickle cell anemia. 56 Genetic testing
can also identify whether the individual is carrier of the disease. 57 A
person who is a "carrier" of the disease does not actually have the
disorder, but may pass that disorder onto his or her child. 58 Finally,
genetic testing can identify whether the individual has a predisposition
to developing the disease, such as cancer, heart disease, or
schizophrenia. 59 An individual who has a predisposition or developing
a disorder may have a gene mutation present, but is currently
other factors will determine whether the individual
asymptomatic and
60
ever becomes ill.
Genetic monitoring can also be performed. Genetic monitoring is
the process whereby an employer, for example, will perform periodic
testing of employees for any chromosomal changes and DNA damage
that might have occurred as a result of working with, or being exposed
to, hazardous substances. 6 1 This process (and practice) is extremely
important and necessary, when used properly and not discriminatorily
applied, because the periodic testing could prevent an employee from
developing an illness associated with his or work.
With the completion of the HGP, employers will have the
capability of obtaining the genetic blueprint of every applicant and
employee. The U.S. Congress Office of Technology (OTA) provides
53

Genetic testing is also referred by many professionals as genetic screening.

See

Rachinsky, supra note 34, at 578.
54Id. Gene tests involve analyzing the individual's DNA and looking for any gene
mutations. Id.
55id.
"6See Gostin, supranote 6, at 110.
57
See Kaufmann, supra note 7, at 411.

58Id.

59See Gostin, supra note 6, at 110.
60

61See Rachinskysupra note

34, at 581.

Edna Lee Sweltz, Genetic Testing in the Workplace: An Analysis ofLegal Implications,
19 FORuM 323, 324 (Winter, 1984).
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62
data on the use of genetic testing and screening in the workplace.
Currently, few companies have elected to partake in genetic screening
of employees; however, a survey of Fortune 500 companies indicated
that twice as many companies are using genetic information today than
just a few years ago. 3 Additionally, a survey conducted by the
Northwestern National Life Insurance Company indicated that 15% of
the companies stated that in the year 2000, they planned on4 initiating
mandatory genetic testing as a pre-condition of employment.
Although some employers have legitimate interests in performing
genetic testing and monitoring, others may use the information for
discriminatory purposes. 65 Allowing employers to gain access to the
employees' private medical information poses severe legal and ethical
dilemmas. First, the medical examinations, to which employees are
often subjected, are not adequately justified by scientific evidence, the
results of which could lead to "false positives." 66 The Scientific
community has also questioned the validity of the results, arguing that a
correlation between the presence or absence of a genetic disorder, and
increased risk of illness has not been found.67 Furthermore, even if a
correlation was found to exist, evidence supporting a link between
screening employees and a reduced chance of illness has not shovM;
rather, other factors, such as drinklng, smoking, and marital status have
been shown to have significant impact in development of the disorder. 6
Being susceptible to a disorder does not, initself, determine the onset
of the disorder; instead, a person's lifestyle choices have serious
implications69 in the overall mental and physical health of that

indiidual.

6See

OTA 171-188 (1990), cited in Gostin, supra note 6, at 115, n.29.

63See Gostin, supra note 6, at 115.
64See Brownlee & Silberner, The Assurances of Gcnes, U.S. News and World Rep., July
23, 1990,
65 at 57, cited in, Gostin, supra note 6, at 115, n.34.

See Sweltz, supra note 61; legitimate interest was discusscd supra page 9.

fsElaine Draper, The Screening of America, The Social and Lcgal Franc.or-r:of
Employees' Use of Genetic Information, 20 BKJ.
. EmLOy. & L a. L. 2,6 1999) A

false positive is where a person has tested positive for a particular disease,but, the parzon doa3
not have the disease. Because results are not necessarily 100%, due to human failure,
contamination, or other factors, false positives can occur.
67See
Sweltz, supra note 61.
6

s1d.

69

1d "
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The screening also evaluates people on future ability to perform
and the probability that the disease will manifest itself, rather than on
actual ability and symptoms of current disease. 70 The information
obtained from the genetic test can also lead to social stratification and
discrimination. 7 1
Because
many
genetic
disorders
are
disproportionately found among specific racial classes, the screening of
individuals for these disorders will mean singling out the races
disproportionately. 72 For example, companies have been found to
screen employees for the sickle-cell trait, found almost exclusively
among African Americans.7 3
Once the employer elects to mandate genetic testing or
monitoring, the employer can then, for example, refuse to hire the
applicant of even fire the employee because of the disorder of
predisposition to a disorder, which leaves the employee without much
remedy.
THE AMERICANS WITH DISABILITIES ACT 74
At present, the ADA is the most effective federal remedy available to
an employee or applicant who is discriminated against because of his or
her genetic makeup; however, the available remedies are limited. 75 The
ADA, promulgated in 1990, extends anti-discrimination protection of
persons with a disability into the private sector arena; 76 however, the
ADA does not provide clear cut answers to questions regarding genetic
discrimination. In fact, the ADA does not even mention genetics or
genetic traits, leaving open the question whether individuals with a
genetic disorder are protected.77

70

See Draper, supra note 66, at 290.
291.

71
1d.at
72

Id.

73

See Sweltz, supra note 61. Two employment discrimination cases have recently
brought suit under Title VII for screening African Americans for the sickle-cell trait. Under
Title VII, it is illegal to discriminate against an individual based on race, religion, sex, or
national origin. 42 U.S.C. §2000e-2.
7442 U.S.C. §12112.
75

See Kaufmann, supra note 7, at 404.
7642 U.S.C. §12112; See Gostin, supra, note 6, at 120.
77See Gostin, supra note 6, at 121.
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An Overview of the Protection Under the ADA
The ADA prevents an employer, with fifteen or more employees, from
discriminating against qualified individuals with a disability in regards
to "job application procedures, the hiring, advancement, or discharge of
employees, employee compensation, job73training, and other terms,
conditions, and privileges of employment."
Under the ADA, an employer is prohibited from conducting preemployment testing on applicants; instead, he must limit the inquiry to
the applicant's ability to perform the job in question. 9 This inquiry
usually involves current physician conditions and usually does not
encompass a genetic disorder. A genetic disorder would, therefore,
only present itself through the use of genetic testing.
Once he extends an offer of employment, the employer can, and
often does, condition the offer on the outcome of a medical
examination.80 In conducting these medical examinations, the employer
is bound by three requirements. First, the employer must not act with
discrimination in deciding whom he tests, and therefore, if the
employer chooses to mandate medical testing, he must do so across the
board. 81 Second, the results of any medical test must be kept
confidential and separate from the application. 2 Finally, the results of
the test may only be used "in accordance with [the] subehapter."3 3 The
sub-chapter, however, does not restrict the employee from testing for
any medical condition and the medical condition does not have to be
job-related or related to a business necessity.84 In theory, the ADA
restricts an employer from discriminating against an employee based on
the results of the examination; however, the ADA's unrealistic
categories limit the individuals who are protected.85
7842 U.S.C. § 12112 (a). Hereinafter, when "employer" is used, it is used in the context
of an employer
with 15 or more employees.
79
Id.at § 12112 (d)(2)(A). An employer does have the limited right to inquire into

disabilities to correct past discrimination; however, the employer must notify the apphcant that
the information is voluntary, confidential, and wvill not be determinative of their employment
with the company.
E0Kaufinann, supra note 7, at 407.
81
1d.
1Id.
8'42 U.S.C. §12112 (d) (3)(C),cited inKaufinann, supra note 7, at 407.

84See Kaufinann, supra note 7, at 408.
'542

U.S.C. §12112(d)(3)(C).
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Once the applicant becomes an employee, the employer may
conduct medical examinations or genetic testing if what is being tested
for is "directly related for doing the task or if necessary for employee
safety." 86 Generally, at this stage, employers have the right to conduct
medical and genetic testing for monitoring purposes.
The ADA does provide a small number of people with protection.
Individuals with a disorder, as defined by the ADA, are protected, and
employers may not discriminate against them because of that disability;
however, a very limited number of individuals with a genetic disorder
actually have a disability.
Establishing a Claim Under the ADA
Definitions
To establish a claim under the ADA, an individual must be able to
show that he: (1) has a disability within the meaning of the Act, (2) was
qualified for the position or promotion, and (3) was denied the position
or promotion because of his disability. 87 The ADA defines a disability
as "(A) a physical or mental impairment that substantially limits one or
more of the major life activities...; (B) a record of such impairment; or
88
(C) being regarded as having such an impairment."
A physical or mental impairment is "any psychological disorder or
condition, cosmetic disfigurement, or anatomical loss affecting one or
more of the following systems: neurological, muskuloskeletal, special
sense organs, respiratory,...cardiovascular, reproductive, digestive,
genito-urinary, hemic and lymphatic, skin, and endocrine." 89 A mental
impairment, as defined by the Equal Employment Opportunity
Commission (EEOC) includes "[a]ny mental or psychological disorder,
such as mental retardation, organic brain syndrome, emotion[al] or
90
mental illness, and specific learning disabilities."

6

Charles Gurd, Whether a Genetic Defect is a Disability Under the Amcricans With
DisabilitiesAct: Preventing Genetic Discriminationby Employers, 1 ANNALS HEALTH L. 107,
110 (1992), cited in Kaufinann, supra note 7, at 409.
8742 U.S.C. § 12112 (a).
"I1d. at § 12102(2).
8929 C.F.R. § 1630.2 (h)(1).
9
Od. at § 1630.2 (h)(2).
9
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The EEOC defines a "major life activity" as anything that deals
with "caring for oneself, performing manual tasks, seeing hearing,
speaking, breathing, learning, working"91 and sexual relationships.
Problems with the ADA

Congress and Courts have recognized that certain disorders cause a
certain amount of impairment in relation to one of the major life
activities, thereby protected under the ADA; however not all, not even
most, of the92genetic disorders fall into the categories set by the ADA
and EEOC.
Mitigating Mfeasure
In June, 1999, the Supreme Court of the United States decided two
separate cases, detrimentally removing any individual who can mitigate

his or disability through corrective measures, 93 from having a disability,
as defined by the ADA.94 In Sutton, two pilots, suffering from severe
myopia, 95 brought suit against respondent, for refusing to hire them as
pilots. 96 In dismissing the claim, the Court held that petitioner did not
have a disability within the meaning of the Act because a disability
must be determined with regard to all corrective measures available to

the individual and whose physical or mental impairment is corrected by
the measure. 97 In Murphy, the Court similarly held that high blood

pressure was not 98a disability, when medication caused petitioner to
function normally.
91

d. at §1630.2(i).
92Gostin, supra note 6, at 123. Dovn Syndrome, muscular dystrophy, cystic fibrosis,
heart disease, schizophrenia, epilepsy, diabetes, and arthritis have all bccn found to qualify as a
disorder;, however, the inquiry is fact specific and depends upon the evcnty and lack of
available
93 medications.
A person with a disability can mitigate the disability through mndication or any other
device that limits the effects of the disability. For example, somebody vho vears contacts,
bringing their vision close to 20/20, would not have a disability within the meanng of the Act.
Sutton v. United Air Lines, Inc., 527 U.S. 471 (1999).
94
Sutton, 527 U.S. 471; Murphy v. United Parcel Service, 527 U.S. 516 (1999).
95
Myopia is a severe sight impairment. Sutton, 527 U.S. 471.
351d. Respondent, airline, had a requirement that all pilots have uncorrected visual acuity
of 201100 or better. Petitioners had 201200 or worse without corrcctcd acuity, but vith
corrective measures, both functioned identically to individuals without similar impairment. Id.
97Id.

9'527 U.S. 516.
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In light of the two recent decisions, fewer individuals with a
genetic disorder will receive the ADA's protection. High blood
pressure and asthma, for example, depending on the severity, can all be
controlled by medication and, therefore, those suffering from these
disorders could not turn to the ADA for protection against
discrimination.
Presence ofActual Disorder
The second major problem with the definitions set by the ADA and
EEOC is the requirement that the individual actually have a current
disorder/disease. This requirement mandates that the employee
(1)
99
actually have a disorder, or (2) be regarded as having a disorder.
The problem with these categories is the creation of the "at risk"
individuals. The "at risk" individuals who do not have a current
genetic disorder, but whose tests indicate a susceptibility to a genetic
disorder, such as breast cancer, are not individuals with a disability
under the ADA, thereby not protected.100 These individuals will be
forced to wait until they symptoms exacerbate before they will be
eligible for ADA protection. The employer could refuse to hire,
promote, or could even fire the employee, leaving him or her without
any relief for the discriminatory treatment.
In addition to individuals with a genetic disorder or susceptibility
to a disorder, carriers of genetic disorders, such as cystic fibrosis, are
left without a federal remedy.10 ' Carriers of genetic disorders do not
actually have the disorder, nor do they have any symptoms of the
disorder, but their offspring may develop the genetic disorder. Because
of the lack of information and stereotypical belief that these individuals
could be discriminated against, yet cannot rely on the ADA for
protection.
Although the ADA offers many individuals with a variety of
disabilities protection, it fails to completely protect individuals with a
genetic disorder. Because of the subjective and unrealistic categories
set by the ADA and EEOC, many employees with genetic disorders are
not protected, leaving them without much alternative legal assistance.
'942 U.S.C. § 12102 (2).
100See Kaufmann, supra note 7, at 411.
""3See Gostin, supra note 6, at 124.
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OTHER EXISTING PROTECTION
At present, employees subjected to genetic discrimination in the
workplace are left without federal assistance. Ostensibly, the federal
government is aware of the growing need for intervention to protect
individuals who are discriminated against based on their genetic
makeup, due to both federal initiatives and statement addressing the
issue. Last year, President Clinton and Vice President Al Gore offered
their support for legislation to protect against workplace genetic
testing.
In his State of the Union Address, President Clinton, inter alia,
asked the nation:
To support this initiative [referring to the 21 1 Century
Research Fund], so that ours will be the generation that
finally wins the war against cancer-and being a revolution
against all disease....As important as rapid scientific progress
is, science must continue to serve humanity-never the other
way around. We must prevent the misuse of genetic tests to
discriminate against any American. 0
Al Gore, addressing the attendants at the Third Annual James
Watson Lecture, presented proposals for new legislation to protect
against genetic discrimination. 104 In that address, Gore suggested that
"we are vulnerable to prejudice" and urged Americans not to
"succumb to it."105 He further stated that the goal of the millenium is
to work "toward ensuring
that our moral code and genetic code are
10 6
forever intertwined."
Although the privacy of medical records already has protection
through the ADA, the Family Medical Leave Act, and the Occupational
Safety and Health Act (OSHA), the President and his administration
maintain that the current restrictions on employers using the

102See Orthmann, supra note 1, at 17.

'°3N.Y. TMEs, January 28, 1998, at A20; WAS-L PosTr, January, 28, 1998, at A25, cited
in Ortbman,supranote 1, at 18.
'°See Ortbmann, supra note 1, at 18.
1OSid.
0

6
1 Id.
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employees' medical files are insufficient.10 7 At the 3 rd Annual James
Watson Lecture, Gore presented the administration's recommendations
8
for preventing genetic discrimination in the workplace.l
The administration recommended three guidelines for future
legislation. First, Gore recommended that employers be prohibited
from requesting or requiring employees or applicants from taking
genetic tests as a condition or benefit of employment. 0 9 Second, he
recommended that employers be prohibited from using any genetic
110
information to discriminate, limit, classify, or segregate employees.
Finally, the administration suggested that employers be denied the
ability to obtain or disclose any genetic information from employees or
11
applicants. '
Despite the proposed regulations, the administration admitted that
genetic screening in the workplace should be permitted under certain
circumstances. Under the proposed regulations, employers could
monitor employees for the effects of hazardous and/or toxic substances
that might cause a genetic disorder.11 2 Additionally, the employers
would be permitted to use the results of the tests to control the adverse
work conditions and prevent future harm. 113 Under these limited
circumstances, the employer would still be restricted in the use of that
information to work safety, would not be permitted to infringe upon the
employee's right of privacy, and could not allow the results to affect
job security.Il
In addition to the President and Vice President, prominent experts
in the scientific, legal, and genetic fields have urged for the passage of
federal
legislation to protect against workplace
genetic
discrimination 1 5 The Director of the NIH's National Center for
Human Genome Research (NCHGR) urged the government to increase
funding for the research of the ethical, legal, and social implications
107Mary Pivek, Mum's the Word on Health, LEGAL TIMES, May 18, 1999, at 44.

108 Orthman, supra note 1, at 18.
'091d. at 18-19.

"ld.
at 19.

11id.
12Id.
1

3

Orthman, supra note 1, at 19.

114Id.
15Id.
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surrounding genetic research. 1 6 Furthermore, the Director stated that
"genetic discrimination in the work-place must no and will not be
tolerated."',17
The Judicial Branch has also recognized the possibility of genetic
discrimination and recently announced its position that genetic
discrimination in the workplace will not be tolerated. 1 In NormanBloodshav v. Lawrence Berkeley Laboratory, employees of a research
facility were tested, without their knowledge, for syphilis, pregnancy,
and sickle-cell anemia." 9 The Ninth Circuit held that the employees'
right under Title VI were violated because the employer only tested
120
women for pregnancy and African Americans for sickle-cell anemia.
The Court concluded that although the employees did not suffer
traditional harms related to employment discrimination, such as denial
of promotion or raises, the employer's unauthorized testing of sensitive
medical information
based on race or sex, in itself, constituted harm
2
VII.
Title
under
Title VII
EstablishingA Clain
Under Title VII, employers, with fifteen or more employees, are
prohibited from discriminating against their employees on the basis of
race, religion, sex, or national origin.12 2 Claims are generally brought
under Title VII through either (1) disparate treatment, or (2) disparate
23
impact.
DisparateTreatment Theory
In the case of Norman-Bloodshiaw, the employees raised the claim of
disparaging treatment, under Title VII. To establish a claim of
disparate treatment, an individual must show the following:
1

1 6Id.
7

1 Id.
8

" See Norman-Bloodshaw v. Lawrence Berkely Laboratory, 135 F3d 1260 (9 Cir.

1998).

119M.

120Md.
12 1

d.
12242 U.S.C.
2

§ 2000e (1994).

1 3See Kaufmaann, supranote 7, at 419.
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He or she is qualified for the job,
That he was rejected by an employer who continued
to seek applications from persons with the
complainant's qualifications.
The employer intended to discriminate against the

3.

employee. 124
Because many genetic disorders, such as sickle cell anemia, are
associated with particular ethnic groups, an employer could require that
a particular class of individuals submit to genetic testing, as did the
employer in Norman-Bloodshaw.125 Title VII disproportionately and
discriminatorily prohibits this singling out of races. The employee
must show that the employer "intended to discriminate against the
individual because of a particular trait."'126 However, because intent is
extremely difficult to prove beyond a preponderance127of the evidence, a
claim under disparate treatment will most likely fail.
DisparateImpact Theory
Because of the likelihood of failure under the disparate treatment
theory, an individual being discriminated against based on his or her
genetic profile, will most likely bring an action based on the disparate
impact theory.
To establish a claim under the disparate impact theory, the
employee must show that the genetic testing or screening "had a
discriminatory effect on groups protected by Title VII.' ' 128 The burden
then shifts to the employer to prove that he had a legitimate business
reason for the screening or testing of the individual(s). 129 If he meets
this burden, the employee must present sufficient evidence to establish
that a less-restrictive viable alternative was available. 130
Establishing a claim under this theory is easier for the employee
because he or she need only establish that he was a member of a
124See Rachinsky, supra note 34.
12Id.
Sickle cell anemia is predominately found among African Americans.
126Kaufimann, supra note 7, at 420.
12
rd"

'zd. at 421.
1291d.
0
13
1d.
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minority31 group (protected class) and was denied because of the
results.1
Legitimate Business Reason

Under both the disparate treatment theory and the disparate impact
theory, the employer can meet its burden by establishing that it had a
legitimate business reason for testing and screening a small number of
employees.
A 'legitimate business reason' denotes the legitimacy in testing
employees, for example, who work with toxic or potential carcinogens.
The employer would require periodic testing of its employees for safety
and overall health. To determine whether the reasons are valid and
justifiable, courts look to the nature of the business involved, 32the
business practice at issue, and the degree of discriminatory impact.1
Under this standard, it would be difficult, if not impossible, for an
employer to justify screening only women or only African Americans;
however, only a small number of individuals can rely on Title VII.
Title VII is only applicable to members of a protected class. If the
individual is not in the protected class, he or she cannot rely on Title
VII for protection.
The Health Insurance Portability and Accountability Act of 1996
The federal legislatures took a step in the right direction in 1996 when
it passed the Health Insurance Portability and Accountability Act,
which took effect in August of 1997.133 HIPAA was enacted to protect
individuals, who might be reluctant to undergo genetic testing out of
fear of reprisal by their health insurance company. 34
HIPAA prohibits insurance companies from instituting rules or
regulations on eligibility for enrollment based on genetic
information. 135 It also prohibits insurance companies from declaring
any susceptibility to a genetic disorder as a pre-existing condition,
"'See Kaufmann, supra note 7.
1321d. at 421.

'3 Sandra N. Hurd, "FederalGovernment Urges Limits on Use of Gcntc Information,"
LAw & POLY REP., 141 (September 1997).
134Id.

' 35See Rachinsky, supra note 34, at 593.
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unless "medical advice, diagnosis, care, or treatment was' ' recommended
136
or received within the 6-month period before enrollment
Any violations of HIPAA could result in public or private causes
137
of action for damages, injunctive relief, and attorney's fees.
Violators could also be subjected to criminal sanctions for the illegal
acquisition of private medical information.
LEGISLATION PROPOSED BY THE 1 0 5T" CONGRESS
Although the federal government has begun to initiate legislation, such
as HIPAA, it fails to adequately protect against genetic discrimination
in the workplace. Because the ADA, Title VII, and HIPAA fail to
circumvent the problem of genetic discrimination, federal legislation
must be instituted before the increased technology destroys our ethical
and moral code.
The federal government has been aware of the possibility of the
adverse affects of beneficial and needed medical technology for some
time. Because of this awareness legislature have attempted to
promulgate statues that prevent against such discriminatory use.
Legislatures have proposed four important pieces of legislation that
would have helped reduce the potentially disastrous effects of the HGP;
however, none of them ever materialized.
The Genetic Privacy and NonDiscrimination Act of 1997138
The Genetic Privacy and NonDiscrimination Act of 1997 (the Privacy
Act) would prohibit insurers and employers from discriminating against
individuals on the basis of their genetic tests. 139 The Privacy Act states,
inter alia,
[g]enetic information is uniquely private and personal information
that should not be disclosed without the authorization of the
36
1 See

Hurd, supra note 133, at 141.

137Id
8
13
See Hurd, supra note 133, at 143. The Act was introduced by Clifford B. Steams (R.

Fla.).

1391d. The privacy act refers to both employers and insurance companies and when

referring to any restriction on part of employer's access, or otherwise, insurance companies are
given equal restrictions. Additionally, when referring to employees, the individuals covered
under health insurance companies enjoy equal protection.
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individual.. .[because] improper disclosure.. .[could] lead to
significant harm.. .including stigmatization and discrimination in

areas

such140 as

employment,

education,

health care,

and

insurance."'

The Privacy Act of 1997 contains three vital provisions that could
potentially alter the discrimination laws in existence toady. First, an
employer would be prohibited from
attempting to acquire.. .or use the genetic information of an
employee or applicant.. .or to require a genetic test.. .for the
purposes of distinguishing among employees or applicants...or for
the purpose of discriminating against or restricting any right or
benefit otherwise due or available to an employee or applicant for
employment, in connection with any
matter relating to
employment, or employment opportunities, including terms and
conditions of employment, privileges and benefits for employees,
and termination of employment.14'

The second restriction would prohibit access to genetic
information, maintaining the privacy of the medical information and
the individual. 142 Finally, the Privacy Act of 1997 would require the
National Bioethics Advisory Committee to submit to congressional
reports recommending the implementation of standards to increase the
protection of the use and storage of DNA and for the further protection
of genetic information.
The Privacy Act of 1997 was sent to the Commerce Committee,
the Committee of Government Reform and Oversight, the Committee
on Education and the Workplace, and the Veterans' Affairs Committee
for consideration. 143 The passage of the Privacy Act would have
important consequential benefits and allow technology to better our
civilization without the negative repercussions that are currently
intertwined with its existence. The Act would permit technology to
advance itself, keeping up with the times, while maintaining the
integrity of the medical field. The congressional reports, required by
the third provision, would permit the legislators, while protecting
'H -.R. 341, cited in Colby, supranote 3, at 472.
4

'1 See Hurd, supra note 133, at 145.
1421d.
W.UI.at 145.
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employees and regulating the behavior of employers, to adapt to the
changes and advancements of our scientific world.
Genetic NonDiscrimination in the Workplace Act
Further along the same lines as the Privacy Act of 1997, Representative
Joseph Kennedy introduced the Genetic Nondiscrimination in the
Workplace Act. 4 4 The Workplace Act of 1997 would prohibit an
employer from obtaining genetic information about an employee or
applicant without the written authorization from the individual. 145 To
obtain legal authorization, the employee would be required to place, in
writing, their name, the employer requesting the information, and the
predictive use of the genetic information.' 4 6 The Workplace Act
further mandates that the employer act in accordance with the ADA,
state law, or any other federal law prohibiting employment
discrimination and/or genetic discrimination.147
The Workplace Act adds an informed consent requirement to the
Privacy Act that would theoretically limit the employer's access;
however, the Workplace Act, alone, is not sufficient. The Workplace
Act is an important piece of legislation in that it prohibits an employer
from obtaining confidential genetic information from its applicants or
employees; however, the act in itself does not prohibit the employer
from requiring the information as a precondition of employment.
Because of this, the employer could demand that his employees consent
to authorization, just as many employers mandate medical
examinations or drug testing. Under the Workplace act, the employer
is only provided with guidelines on the testing and use of the genetic
information.
Therefore, in order to provide a more comprehensive legislation
and protection against genetic discrimination in the workplace, federal
legislators need to institute a combination of multiple bills that would
prevent an employer from requiring a genetic test and prohibit
employer access. An exception would need to be instituted whereby an
144H.R.2215; The Genetic Discrimination in the Workplace Act [hereinafter the
Workplace Act of 1997] was introduced on July 22, 1997 by Rep. Joseph Kennedy (D-Mass).
See also45Hurd, supra note 133, at 145.
1 id.
146See Hurd, supra note 133, at 145.
1471d. at 146.
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employer whose company deals in toxic or potentially hazardous
substances should have limited access to genetic monitoring, to screen
for potential DNA abnormalities, and institute any necessary safety and
health precautions. This information, however, should only be available
to qualified medical personnel who could act as a liaison between the
employer and the employee, thus ensuring the nondiscriminatory use of
the information.
Genetic Confidentiality and NonDiscrimination Act
Adding the Genetic Confidentiality and Nondiscrimination to the
Workplace Act and Privacy Act would ultimately complete the set of
legislation, furnishing comprehensive protection to employees, while at
the same time permitting employer access to monitor health and safety
measures. The Genetic Confidentiality and Nondiscrimination Act,
introduced by Sen. Pete V. Domenici, adds another piece to the
important restrictions needed to prevent discrimination. 14'
The
Nondiscrimination Act focuses its regulations on the manner in which
the DNA samples and genetic information is collected, stored, and
analyzed. 149 The Nondiscrimination Act sets forth detailed obligations
of the DNA collector. 150 The collector of the genetic information
would be required to present information stating that the individual
being tested voluntarily consents to the procedure, provide an
explanation of the possible uses of genetic testing, and explain what
information -willbe given to the provider of the DNA material.'
The
collector would further be required to inform the provider of his or her
rights to: (1) invoke the consent at any
time, (2) destroy the DNA at
1 52
any time, and (3) genetic counseling.
The Nondiscrimination Act provides yet another aspect, lacking in
other genetic discrimination acts. It prohibits an employer from
requiring, using, or gaining access to the employee's genetic
43

MId. S. 422 [hereinafter the Nondiscrimination Act]. Sce also Hurd, suipranote 133, at
146.

149

See Hurd, supranote 133, at 146.
'-'Od. Hereinafter, the individual who is undergoing genetic testing will be referred to as
the "provider," and the medical professional eliciting the genetic informution vaill ba referred to
as the "collector."
1511d.
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DEPAUL JOURNAL OF HEALTH CARE LAW[

[Vol, 4:423

information. 153 The latter part of the act attempts to limit the possibility
of misuse of the genetic material, while still allowing
the employees to
54
partake in genetic testing for their own benefit.1
The Genetic Justice Act
The Genetic Justice Act, introduced in July 1997, would prohibit preemployment genetic testing as a precondition of employment and
require that employers restrict genetic testing to current employees with
job offers. 155 Although the Justice Act permits an employee to request
a genetic test once an offer of employment is extended, the employer
may only request such information as it relates to a business
necessity.156
The Act would also prohibit an employer from
57
segregating the employees based on the genetic information elicited.1
Genetic discrimination, a serious and rapidly increasing problem,
will continue until the government institutes federal legislation
protecting the hard working citizens and non-citizens of this great
country. The 1 0 5th Congress attempted to circumvent this problem by
instituting a variety of statutes that would reduce the possibility of
misuse of genetic testing, while maintaining the integrity of the
technological world.
Despite this attempt, the 10 5 th Congress
ultimately failed because no such federal law has been passed as of yet.
The 10 6th Congress has further addressed the issue and sent several
more congressional reports and bills to committees for review.
CONCLUSION
With the turn of the century, our civilization began relying more on the
medical and scientific communities to improve the quality of life and
better our world. As we enter the new millennium, it is apparent that
the world, as we know it today, will be forever changed. Scientists and
1531d.
'-See Hurd, supra note 133, at 146.

The Nondiscrimination Act would also prohibit

insurance companies from discriminating against healthy individuals on the basis of genetic
information or request genetic information. The Act would also prohibit insurance companies
from requiring
an applicant to take a genetic test before coverage is offered.
1551d. S. 1045; see also Hurd, supra note 133, at 147. The Genetic Justice Act
[hereinafter the Justice Act] was introduced by Sen. Thomas Daschle (D-SD).
1561d.
'57Id.
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Geneticists have begun to sequence the entire human genome, mapping
specific genes with certain genetic disorders. 53 By the year 2003, the
HGP is set to be completed and its goal satisfied, where an individual
will be able to undergo a simple blood test and from that test medical
professionals will be able to determine three important pieces of
information. First, results of any test will determine whether the
individual has any genetic disorders or chromosomal abnormalities.
Second, the results would indicate whether the individual is carrier of
any genetic disorders.15 9 Finally, the results would determine whether
the individual was susceptible to developing a disorder, such as heart
disease or breast cancer.16° It is important to keep in mind, however,
that being susceptible to a disorder is not a guarantee of development of
that disorder, but rather multiple factors
have serious implications on
16
disorder.
that
of
development
the actual
The results of the genetic test have both beneficial and potentially
disastrous results. With the testing, comes the ability to treat, prevent,
and cure all genetic disorders through the use of genetic counseling and
manipulation. 162 Increased research is necessary to help cure
individuals suffering from a potentially life-threatening illness, such as
cystic fibrosis; however, the possibility of discrimination should not be
over-looked. Specifically, genetic discrimination in the workplace has
already begun and will continue to rise in numbers throughout this
century. An employer, for example, could require all employees and
applicants to undergo genetic testing to determine their current and
future health and then refuse to hire (or fire) the individual based on the
results.
If discrimination does occur, the employee is left with few
remedies. The ADA limits protection to individuals with a current
disorder that interferes with a major life activity. 163 Most genetic
disorder, however, are controlled by medication, and in light of Sutton
and Murphy, are taken out of the category of protected individuals.
Additionally, carriers and individuals with susceptibility are not
)SHudson, supra note 5, at 395.
59
11601d.
Gostin, supra note 6, at 109.

1611d.
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163See Kaufinann, supra note 7, at 410.
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individuals with a disability under the Act and not protected. 164 The
effect of the definition set by the ADA and EEOC ultimately gives the
employer the right to discriminate against these individuals, and leaves
most employees without a remedy to rectify the negative, prejudicial
treatment.
Title VII can also be used to combat genetic discrimination, but it
can only be applied to those individuals falling into a protected class.
Unfortunately, very few individuals have disability or disorders that
would render them protected. Even if the employee were a member of
a protected class, the employer would rebut the testimony with a
legitimate business reason for its actions.
Members of the 10 5 th and the 10 6th Congress took a step in the
right direction by sending several important pieces of legislation to
Committees for review. Although legislators have begun to take some
notice of the potentially disastrous affects of the HGP and have
attempted to intervene, they have failed to pass any legislation that
protected every working individual in this county.
The federal government must take the initiative and stop genetic
discrimination before it becomes a common practice. Without such
coverage our moral and ethical code will forever be superseded by the
technological, scientific, and medical world.

